Description |
leucine rich pentatricopeptide repeat containing |
PPARG coactivator 1 alpha |
Image |
No pdb structure |
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Alcohol consumption (drinks per week) ( 30679032)
- Alcohol use disorder (consumption score) ( 33861876)
- Bitter alcoholic beverage consumption ( 31046077)
- Chronotype ( 30696823)
- Frailty index ( 34431594)
- Hand grip strength ( 29691431 29313844)
- Levodopa-induced dyskinesia in levodopa treated Parkinson's disease ( 32733355)
- Medication use (calcium channel blockers) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Morning person ( 30696823)
- Refractive error ( 32231278)
- Smoking status (ever vs never smokers) ( 30643258)
|
- Aspartate aminotransferase levels ( 33547301)
- Coffee consumption ( 31046077)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Corneal astigmatism ( 29422769)
- Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098)
- Essential tremor ( 27797806)
- Estimated glomerular filtration rate ( 31152163 31015462)
- Hematocrit ( 32888494)
- Hemoglobin ( 32888494)
- Intralaminar thalamic nuclei volume ( 34006833)
- Lead levels ( 26025379)
- Molar-incisor hypomineralization ( 23918034)
- PR interval ( 32439900)
- Refractive error ( 32231278)
- Resting heart rate ( 27798624)
- Rosacea symptom severity ( 29771307)
- Schizophrenia ( 30285260)
- Subjective response to placebo treatment in childhood asthma (change in cough/wheeze) ( 31557306)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010)
|
Interacting Genes |
83 interacting genes:
ANKRD1
AP2A2
CECR2
FOXO1
HEBP2
LINC01554
MAP1S
MIR1-1
MIR1-2
MIR106A
MIR106B
MIR107
MIR10B
MIR122
MIR128-1
MIR128-2
MIR138-1
MIR138-2
MIR140
MIR141
MIR143
MIR145
MIR155
MIR15A
MIR15B
MIR16-1
MIR16-2
MIR17
MIR18A
MIR18B
MIR199A1
MIR199A2
MIR19A
MIR19B1
MIR19B2
MIR200A
MIR200B
MIR200C
MIR205
MIR206
MIR20A
MIR20B
MIR21
MIR214
MIR221
MIR222
MIR25
MIR29A
MIR29B1
MIR29B2
MIR29C
MIR31
MIR34A
MIR34B
MIR34C
MIR363
MIR429
MIR451A
MIR7-1
MIR7-2
MIR7-3
MIR9-1
MIR9-2
MIR9-3
MIR92A1
MIR92A2
MIR93
MIR98
MIRLET7A1
MIRLET7A2
MIRLET7A3
MIRLET7B
MIRLET7C
MIRLET7D
MIRLET7E
MIRLET7F1
MIRLET7F2
MIRLET7G
MIRLET7I
NFKBIB
PPARGC1A
PTEN
UXT
|
44 interacting genes:
CAPNS1
CDK6
CREBBP
ESR1
ESR2
ESRRA
ESRRG
FBXW7
GSK3B
HCFC1
HNF4A
LRPPRC
MAPK14
MED1
MED12
MED14
MED17
MYBBP1A
NCL
NCOA1
NCOA6
NDN
NR1H4
NR1I2
NR1I3
NR3C1
NRF1
PCDH7
PPARA
PPARD
PPARG
RARB
RXRA
SIRT1
SKP1
SRSF4
SRSF5
SRSF6
THRB
TP53
UBC
UBE2I
USF1
USF2
|
Entrez ID |
10128 |
10891 |
HPRD ID |
06343 |
05155 |
Ensembl ID |
ENSG00000138095
|
ENSG00000109819
|
Uniprot IDs |
E5KNY5
P42704
|
A0A024R9Q9
Q9UBK2
|
PDB IDs |
|
1XB7
3B1M
3CS8
3D24
3U9Q
3V9T
3V9V
4QJR
4QK4
5Q0I
5TWO
5UNJ
5Z5S
5Z6S
6AD9
6FZF
6FZP
6IZM
6IZN
6K0T
6KXX
6KXY
6LN4
6MS7
6NWK
6NWL
6W9K
6W9L
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|